Developmental Therapeutics Inc (EIN 311183763) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1986

Legal Domicile

Principal Officer

J Taliesin Richards

Phone

5135588997

Tax Period

2022-01-01 to 2022-12-31

Developmental Therapeutics Inc, founded in 1986, is a small nonprofit in the Health Care sector that reported $505K in total revenue in fiscal year 2022. Revenue fell 67% from the prior year — a significant decline worth monitoring. Expenses of $1.2M exceeded revenue, resulting in a 128% operating deficit.

Mission

Improves lives throughout the world by providing the highest quality products that are possible to improve the health and lives of others. We perform pancreatic islet cell isolation procedures. In doing so, we maintain the highest standards in performing clinical cell processing operations Policies and procedures are in place to ensure regulatory compliance.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2022)

Revenue Breakdown

Contributions & Grants $0

Program Service Revenue $505,000

Investment Income $0

Other Revenue $0

TOTAL REVENUE $505,000

Expense Breakdown

Grants Paid $700,000

Salaries & Benefits $78,000

Fundraising Expenses $0

Program Expenses $1,057,860

Other Expenses $373,026

TOTAL EXPENSES $1,151,026

Year-over-Year Comparison

	2022	2021	Change
Revenue	$505,000	$1,520,086	-0.7%
Expenses	$1,151,026	$1,683,367	-0.3%
Net Income	$-646,026	$-163,281	+3.0%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$764,237

Total Directors

$764,237

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Dr Jeffrey Sussman	Board Member	2.00	Officer Director	$18,000	$54,000	$222,000
Taliesin Richards	Executive Director	5.00	Officer Director	$60,000	$29,959	$173,179
Dr Syed Ahmad	Board Member	2.00	Officer Director	$0	$97,692	$369,058

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	No data	No data	No data	No data
2024	No data	No data	No data	No data
2022	$505,000	$1,151,026	$379,787	$-646,026
2021	$1,520,086	$1,683,367	$1,025,813	$-163,281
2020	$1,220,000	$1,628,491	$1,189,094	$-408,491
2019	$1,125,000	$816,397	$1,597,585	$308,603
2018	$1,341,000	$1,370,183	$1,288,982	$-29,183

Developmental Therapeutics Inc